Cargando…
Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the neurodegenerative start several years before the appearance of clinical symptoms. In this brief review, we comment on some molecular and cellular markers appearing at different stages of the disease,...
Autores principales: | Pérez, Mar, Hernández, Félix, Avila, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554800/ https://www.ncbi.nlm.nih.gov/pubmed/32942527 http://dx.doi.org/10.3390/ijms21186749 |
Ejemplares similares
-
Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010) -
A Graph Convolutional Network Based on Univariate Neurodegeneration Biomarker for Alzheimer’s Disease Diagnosis
Publicado: (2023) -
Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
por: Wu, Xi-Lin, et al.
Publicado: (2017) -
In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020) -
Oral frailty and neurodegeneration in Alzheimer’s disease
por: Dibello, Vittorio, et al.
Publicado: (2021)